Featured publications

• Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis

  Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW;

  (...)

  Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME .

  See complete list of authors

  Reference:

  Journal Of Allergy And Clinical Immunology 2019.

• Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

  Jones RB; Hiemstra TF; Ballarin J; Blockmans DE; Brogan P;

  (...)

  Walsh D; Walters G; Harper L; Jayne D; European Vasculitis Study Group (EUVAS).

  See complete list of authors

  Reference:

  Annals Of The Rheumatic Diseases 2019.

• Expression and function of IL12/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: Contribution of p40 to Th1-and Th17-mediated inflammatory pathways

  Espigol-Frigole, Georgina; Planas-Rigol, Ester; Lozano, Ester; Corbera-Bellalta, Marc; Terrades-Garcia, Nekane;

  Prieto-Gonzalez, Sergio; Garcia-Martinez, Ana; Hernandez-Rodriguez, Jose; Grau, Josep M; Cid, Maria C.

  Reference:

  Frontiers In Immunology 2018.

• Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: A mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

  Planas-Rigol, Ester; Terrades-Garcia, Nekane; Corbera-Bellalta, Marc; Lozano, Ester; Alba, Marco A;

  (...)

  Prieto-Gonzalez, Sergio; Hernandez-Rodriguez, Jose; Preciado, Sara; Lavilla, Rodolfo; Cid, Maria C.

  See complete list of authors

  Reference:

  Annals Of The Rheumatic Diseases 2017.

• Trial of Tocilizumab in Giant-Cell Arteritis.

  Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M;

  (...)

  Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N .

  See complete list of authors

  Reference:

  New England Journal Of Medicine 2017.

• Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

  Wechsler, M E; Akuthota, P; Jayne, D; Khoury, P; Klion, A;

  (...)

  Philipson, R; Yancey, S W; Steinfeld, J; Weller, P F; Gleich, G J;EGPA Mepolizumab Study Team.

  See complete list of authors

  Reference:

  New England Journal Of Medicine 2017.

• A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

  Carmona FD; Vaglio A; Mackie SL; Hernández-Rodríguez J; Monach PA;

  (...)

  Morgan AW; González-Gay MA; Martín J Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium.

  See complete list of authors

  Reference:

  American Journal Of Human Genetics 2017.

• Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

  Corbera-Bellalta, Marc; Planas-Rigol, Ester; Lozano, Ester; Terrades-Garcia, Nekane; Alba, Marco A;

  (...)

  Roux-Lombard, Pascale; Ferlin, Walter G; Dayer, Jean-Michel; Kosco-Vilbois, Marie H; Cid, Maria C.

  See complete list of authors

  Reference:

  Annals Of The Rheumatic Diseases 2016.

• Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling

  Espigol-Frigole, Georgina; Planas-Rigol, Ester; Ohnuki, Hidetaka; Salvucci, Ombretta; Kwak, Hyeongil;

  Ravichandran, Sarangan; Luke, Brian; Cid, Maria C; Tosato, Giovanna.

  Reference:

  Science Signaling 2016.

• Changes in biomarkers after therapeutic intervention in temporal arteries cell arteritis

  Corbera-Bellalta, Marc; Garcia-Martinez, Ana; Lozano, Ester; Planas-Rigol, Ester; Tavera-Bahillo, Itziar;

  (...)

  Fernandez, Pedro L; Roux-Lombard, Pascale; Dayer, Jean-Michel; Rahman, Mahboob U; Cid, Maria C.

  See complete list of authors

  Reference:

  Annals Of The Rheumatic Diseases 2014.